TradeFlare's AI research teams analysed BIIB on 11 market nights between June 3, 2026 and October 1, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| October 1, 2026 | HOLD | $225.88 | — / — | -2.0% | not yet | The current market and stock setup does not warrant a directional trade. |
| September 24, 2026 | HOLD | $227.53 | — / — | -1.6% | not yet | The current market conditions and BIIB's technical setup do not warrant a buy at this time. |
| September 3, 2026 | HOLD | $222.67 | — / — | -3.3% | -2.1% | The stock is at a resistance level and lacks strong technical conviction for an immediate buy. |
| August 5, 2026 | BUY | $208.45 | $230.00 / $177.18 | +1.1% | +7.8% | The post-earnings drift signal suggests a potential for continued upward momentum over a few weeks. |
| August 4, 2026 | BUY | $201.82 | $232.09 / $171.55 | -2.2% | +3.6% | The post-earnings drift (PEAD) signal suggests a sustained upward move. |
| August 3, 2026 | BUY | $202.95 | — / — | +2.6% | +7.3% | Positive news sentiment driven by strong Q2 earnings and revenue growth from newer drug portfolio. |
| July 31, 2026 | BUY | $207.93 | — / — | +2.5% | +7.7% | The current market and stock setup does not warrant a trade. |
| July 30, 2026 | BUY | $209.23 | — / — | -0.8% | +6.5% | Continued positive sentiment driven by strong Q2 earnings and revenue. |
| July 13, 2026 | BUY | $199.15 | — / — | -4.3% | -0.9% | The current market regime is neutral, and BIIB lacks strong directional conviction from the teams. |
| July 10, 2026 | BUY | $198.91 | — / — | +3.4% | +4.4% | The current market regime is neutral, and BIIB's technicals are bearish, making it unsuitable for a buy. |
| June 3, 2026 | BUY | $188.83 | — / — | -0.9% | +10.3% | Successful clinical trial results for new drug candidates. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.